News
Bausch + Lomb is to invest €90m in Waterford adding 130 additional jobs
From IDA Ireland; Department of Enterprise, Trade and Employment
Published on
Last updated on
From IDA Ireland; Department of Enterprise, Trade and Employment
Published on
Last updated on
Bausch + Lomb, a leading global eye health company, today announced plans to invest €90m to expand manufacturing operations at its Waterford facility.
The investment is expected to generate 130 additional jobs when production commences in 2023 and will provide the Waterford facility with additional capacity to meet expected demand for its Biotrue ONEday® range of contact lenses. In addition, approximately 150 additional workers are expected to be employed in the construction phase of the expansion.
The investment will further strengthen the Waterford plant’s position in supporting Bausch + Lomb’s efforts to increase market share in the contact lens market. This follows a similar announcement in November 2018 in which the company announced it was investing to increase contact lens manufacturing capacity at its sites in Waterford and Rochester, N.Y. by adding multiple production lines at these two sites to support the manufacture of its innovative daily disposable silicone hydrogel (SiHy daily) contact lenses.
Construction of the Waterford facility, announced in 2018, has now been completed, and production of the company’s latest contact lenses, Bausch + Lomb INFUSE®, will start by the end of this year. The Waterford site currently employs more than 1,500 people.
Tánaiste and Minister for Enterprise, Trade and Employment Leo Varadkar TD said:
"I warmly welcome this news that Bausch + Lomb is investing a further €90 million in Waterford, creating 130 new jobs for the county. The company has already invested significantly in the South East region, employing over 1,500. This decision reaffirms that commitment and is a great vote of confidence in Waterford and all it has to offer. I wish all involved the very best with this new development and thank Bausch + Lomb for the continuing commitment to Ireland."
Mark Hennessy, Site Lead, Bausch + Lomb, Waterford, said:
"Our Vision is to be the Global Leader in Contact Lens Innovation and Manufacturing, and this latest investment will enable the Waterford facility to meet the growing demand for our very successful Biotrue ONEday® range of daily disposable contact lenses. The Biotrue lens was developed by the team in Waterford and supported by our commercial colleagues around the world, and it continues to grow in our U.S., European and Asian markets.
"We recently celebrated the 40th anniversary of the establishment of Bausch + Lomb Waterford, and the decision to make this significant investment in Waterford was influenced by our track record in providing high-quality products and excellent customer service to markets around the globe."
IDA Ireland CEO Martin Shanahan said:
"IDA Ireland has partnered with Bausch + Lomb for many years. We are delighted with the company’s decision to further expand its manufacturing operations at the Waterford facility, creating 130 jobs. It demonstrates Bausch + Lomb’s continued commitment to the South East region, in which, this year, it celebrates its 40th anniversary. This expansion is a welcome addition to the South East Region’s thriving MedTech cluster. I want to wish Bausch + Lomb every success with this expansion and assure it of IDA Ireland’s continued support."
Recruitment for the new jobs will begin in 2022. However, the facility currently has vacant positions in operations, engineering, quality and other disciplines.
To view these open positions please visit the link below and click on IE - Waterford in the “Location” drop down menu:
Media contact:
Michael Bance, Mobile +353 872462875; michael@bancenolan.ie
IDA Ireland Press Office:
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., is solely focused on helping people see. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in approximately 100 countries. For more information, visit www.bausch.com.